مصطلحات الفهرس: animal model, animal tissue, article, comparative study, controlled study, drug potency, drug potentiation, early intervention, glomerulosclerosis, glucose blood level, hemoglobin blood level, human, hypertension, IC50, kidney function, kidney injury, male, monocyte, mouse, nephritis, nonhuman, podocyte, priority journal, animal experiment, streptozotocin-induced diabetic nephropathy/co [Complication], streptozotocin-induced diabetic nephropathy/dt [Drug Therapy], systolic blood pressure, albumin/ec [Endogenous Compound], captopril/cb [Drug Combination], captopril/dt [Drug Therapy], captopril/po [Oral Drug Administration], captopril/pd [Pharmacology], CD68 antigen/ec [Endogenous Compound], chemokine receptor CCR2 antagonist/cb [Drug Combination], chemokine receptor CCR2 antagonist/dt [Drug Therapy], chemokine receptor CCR2 antagonist/po [Oral Drug Administration], chemokine receptor CCR2 antagonist/pd [Pharmacology], cystatin C/ec [Endogenous Compound], endothelial nitric oxide synthase/dt [Drug Therapy], endothelial nitric oxide synthase/ec [Endogenous Compound], glucose/ec [Endogenous Compound], hemoglobin A1c/ec [Endogenous Compound], messenger RNA/ec [Endogenous Compound], protective agent/cb [Drug Combination], protective agent/dt [Drug Therapy], protective agent/po [Oral Drug Administration], protective agent/pd [Pharmacology], tumor necrosis factor/ec [Endogenous Compound], unclassified drug, pf 04634817/cb [Drug Combination], pf 04634817/dt [Drug Therapy], pf 04634817/po [Oral Drug Administration], pf 04634817/pd [Pharmacology], renal protection, animal cell, albuminuria, Article

URL: American Journal of Physiology - Renal Physiology
Click here for full text options
LibKey Link

مصطلحات الفهرس: chronic kidney failure, diabetic nephropathy/dt [Drug Therapy], enzyme activation, enzyme inhibition, human, priority journal, protein targeting, apoptosis signal regulating kinase 1/ec [Endogenous Compound], protein serine threonine kinase inhibitor/dt [Drug Therapy], protein serine threonine kinase inhibitor/pv [Special Situation for Pharmacovigilance], nonhuman, acute kidney failure, article, cardiorenal syndrome, Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/29128Test
Anatomical Record
Click here for full text options
LibKey Link

مصطلحات الفهرس: animal model, animal tissue, article, comparative study, controlled study, drug potency, drug potentiation, early intervention, glomerulosclerosis, glucose blood level, hemoglobin blood level, human, hypertension, IC50, kidney function, kidney injury, male, monocyte, mouse, nephritis, nonhuman, podocyte, priority journal, animal experiment, streptozotocin-induced diabetic nephropathy/co [Complication], streptozotocin-induced diabetic nephropathy/dt [Drug Therapy], systolic blood pressure, albumin/ec [Endogenous Compound], captopril/cb [Drug Combination], captopril/dt [Drug Therapy], captopril/po [Oral Drug Administration], captopril/pd [Pharmacology], CD68 antigen/ec [Endogenous Compound], chemokine receptor CCR2 antagonist/cb [Drug Combination], chemokine receptor CCR2 antagonist/dt [Drug Therapy], chemokine receptor CCR2 antagonist/po [Oral Drug Administration], chemokine receptor CCR2 antagonist/pd [Pharmacology], cystatin C/ec [Endogenous Compound], endothelial nitric oxide synthase/dt [Drug Therapy], endothelial nitric oxide synthase/ec [Endogenous Compound], glucose/ec [Endogenous Compound], hemoglobin A1c/ec [Endogenous Compound], messenger RNA/ec [Endogenous Compound], protective agent/cb [Drug Combination], protective agent/dt [Drug Therapy], protective agent/po [Oral Drug Administration], protective agent/pd [Pharmacology], tumor necrosis factor/ec [Endogenous Compound], unclassified drug, pf 04634817/cb [Drug Combination], pf 04634817/dt [Drug Therapy], pf 04634817/po [Oral Drug Administration], pf 04634817/pd [Pharmacology], renal protection, animal cell, albuminuria, Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/35302Test
American Journal of Physiology - Renal Physiology
LibKey Link

مصطلحات الفهرس: chronic kidney failure, diabetic nephropathy/dt [Drug Therapy], enzyme activation, enzyme inhibition, human, priority journal, protein targeting, apoptosis signal regulating kinase 1/ec [Endogenous Compound], protein serine threonine kinase inhibitor/dt [Drug Therapy], protein serine threonine kinase inhibitor/pv [Special Situation for Pharmacovigilance], nonhuman, acute kidney failure, article, cardiorenal syndrome, Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/29128Test
Anatomical Record
LibKey Link

مصطلحات الفهرس: randomized controlled trial, risk assessment, treatment duration, trough concentration, unspecified side effect/si [Side Effect], urinary excretion, urinary tract infection/dt [Drug Therapy], albumin/ec [Endogenous Compound], alfentanil/cb [Drug Combination], angiotensin receptor antagonist/dt [Drug Therapy], antibiotic agent/dt [Drug Therapy], astemizole/cb [Drug Combination], cisapride/cb [Drug Combination], clarithromycin/cb [Drug Combination], conivaptan/cb [Drug Combination], creatinine/ec [Endogenous Compound], cyclosporine/cb [Drug Combination], dihydroergotamine/cb [Drug Combination], dipeptidyl carboxypeptidase inhibitor/dt [Drug Therapy], ergotamine/cb [Drug Combination], fentanyl/cb [Drug Combination], indinavir plus ritonavir/cb [Drug Combination], itraconazole/cb [Drug Combination], ketoconazole/cb [Drug Combination], lopinavir plus ritonavir/cb [Drug Combination], pimozide/cb [Drug Combination], placebo, quinidine/cb [Drug Combination], rapamycin/cb [Drug Combination], reduced nicotinamide adenine dinucleotide phosphate oxidase/ec [Endogenous Compound], ritonavir/cb [Drug Combination], setanaxib/ae [Adverse Drug Reaction], setanaxib/ct [Clinical Trial], setanaxib/cb [Drug Combination], setanaxib/cm [Drug Comparison], setanaxib/cr [Drug Concentration], setanaxib/dt [Drug Therapy], setanaxib/pd [Pharmacology], tacrolimus/cb [Drug Combination], telaprevir/cb [Drug Combination], terfenadine/cb [Drug Combination], voriconazole/cb [Drug Combination], setanaxib/pk [Pharmacokinetics], clinical evaluation, clinical protocol, adult, aged, albuminuria/dt [Drug Therapy], animal experiment, antibiotic therapy, article, controlled study, creatinine blood level, creatinine urine level, diabetic nephropathy/dt [Drug Therapy], diabetic patient, double blind procedure, drug blood level, drug efficacy, drug safety, drug withdrawal, estimated glomerular filtration rate, female, human, insulin dependent diabetes mellitus/dt [Drug Therapy], major clinical study, male, microalbuminuria, mouse, multicenter study, nonhuman, outcome assessment, patient compliance, phase 2 clinical trial, physician, Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/29385Test
Contemporary Clinical Trials
LibKey Link

مصطلحات الفهرس: human, kidney injury, nephrectomy, non insulin dependent diabetes mellitus/dt [Drug Therapy], nonhuman, podocyte, priority journal, ureter obstruction, cathepsin S/ec [Endogenous Compound], CD68 antigen/ec [Endogenous Compound], inducible nitric oxide synthase/ec [Endogenous Compound], proteinase activated receptor 2/ec [Endogenous Compound], unclassified drug, ro 5461111/dt [Drug Therapy], cathepsin S inhibitor/dt [Drug Therapy], albuminuria, body weight, db/db mouse, diabetic nephropathy/dt [Drug Therapy], editorial, endothelial dysfunction, enzyme activation, enzyme activity, experimental diabetic nephropathy, glomerulosclerosis, glucose blood level, Editorial

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/39672Test
Journal of the American Society of Nephrology
Click here for full text options
LibKey Link

مصطلحات الفهرس: review, acute kidney failure, chronic kidney disease, signal transduction, ureter obstruction, apoptosis signal regulating kinase 1/ec [Endogenous Compound], mitogen activated protein kinase p38/ec [Endogenous Compound], phosphotransferase inhibitor/dt [Drug Therapy], diabetic nephropathy/dt [Drug Therapy], unclassified drug, ASK1 gene, apoptosis signal regulating kinase 1 inhibitor/dt [Drug Therapy], stress activated protein kinase/ec [Endogenous Compound], disease course, disease severity, drug selectivity, enzyme activation, fibrosing alveolitis, gene, homeostasis, human, kidney disease/dt [Drug Therapy], kidney disease/et [Etiology], nonhuman, priority journal, renal protection, reperfusion injury, Review

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/39841Test
American Journal of Physiology - Renal Physiology
Click here for full text options
LibKey Link

مصطلحات الفهرس: insulin dependent diabetes mellitus, macrophage, male, mouse, nonhuman, podocyte, priority journal, renal protection, signal transduction, systolic blood pressure, albumin/ec [Endogenous Compound], apoptosis signal regulating kinase 1/ec [Endogenous Compound], CD6 antigen/ec [Endogenous Compound], collagen type 4/ec [Endogenous Compound], cystatin C/ec [Endogenous Compound], endothelial nitric oxide synthase/ec [Endogenous Compound], fibronectin/ec [Endogenous Compound], glucose/ec [Endogenous Compound], hemoglobin A1c/ec [Endogenous Compound], kidney injury molecule 1/ec [Endogenous Compound], messenger RNA/ec [Endogenous Compound], mitogen activated protein kinase p38/ec [Endogenous Compound], monocyte chemotactic protein 1/ec [Endogenous Compound], plasminogen activator inhibitor 1/ec [Endogenous Compound], protein serine threonine kinase inhibitor/dt [Drug Therapy], protein serine threonine kinase inhibitor/po [Oral Drug Administration], protein serine threonine kinase inhibitor/pd [Pharmacology], RNA/ec [Endogenous Compound], streptozocin, transforming growth factor beta1/ec [Endogenous Compound], unclassified drug, urinary tract agent/dt [Drug Therapy], urinary tract agent/po [Oral Drug Administration], urinary tract agent/pd [Pharmacology], WT1 protein/ec [Endogenous Compound], gs 444217/dt [Drug Therapy], gs 444217/po [Oral Drug Administration], gs 444217/pd [Pharmacology], albuminuria, animal cell, animal experiment, animal model, animal tissue, article, cell loss, controlled study, diabetic nephropathy/dt [Drug Therapy], disease course, early intervention, enzyme inhibition, glomerulosclerosis, glucose blood level, hypertension, IC50, in vitro study, Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/41052Test
Diabetes
Click here for full text options
LibKey Link

مصطلحات الفهرس: review, acute kidney failure, chronic kidney disease, signal transduction, ureter obstruction, apoptosis signal regulating kinase 1/ec [Endogenous Compound], mitogen activated protein kinase p38/ec [Endogenous Compound], phosphotransferase inhibitor/dt [Drug Therapy], diabetic nephropathy/dt [Drug Therapy], unclassified drug, ASK1 gene, apoptosis signal regulating kinase 1 inhibitor/dt [Drug Therapy], stress activated protein kinase/ec [Endogenous Compound], disease course, disease severity, drug selectivity, enzyme activation, fibrosing alveolitis, gene, homeostasis, human, kidney disease/dt [Drug Therapy], kidney disease/et [Etiology], nonhuman, priority journal, renal protection, reperfusion injury, Review

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/39841Test
American Journal of Physiology - Renal Physiology
LibKey Link

مصطلحات الفهرس: insulin dependent diabetes mellitus, macrophage, male, mouse, nonhuman, podocyte, priority journal, renal protection, signal transduction, systolic blood pressure, albumin/ec [Endogenous Compound], apoptosis signal regulating kinase 1/ec [Endogenous Compound], CD6 antigen/ec [Endogenous Compound], collagen type 4/ec [Endogenous Compound], cystatin C/ec [Endogenous Compound], endothelial nitric oxide synthase/ec [Endogenous Compound], fibronectin/ec [Endogenous Compound], glucose/ec [Endogenous Compound], hemoglobin A1c/ec [Endogenous Compound], kidney injury molecule 1/ec [Endogenous Compound], messenger RNA/ec [Endogenous Compound], mitogen activated protein kinase p38/ec [Endogenous Compound], monocyte chemotactic protein 1/ec [Endogenous Compound], plasminogen activator inhibitor 1/ec [Endogenous Compound], protein serine threonine kinase inhibitor/dt [Drug Therapy], protein serine threonine kinase inhibitor/po [Oral Drug Administration], protein serine threonine kinase inhibitor/pd [Pharmacology], RNA/ec [Endogenous Compound], streptozocin, transforming growth factor beta1/ec [Endogenous Compound], unclassified drug, urinary tract agent/dt [Drug Therapy], urinary tract agent/po [Oral Drug Administration], urinary tract agent/pd [Pharmacology], WT1 protein/ec [Endogenous Compound], gs 444217/dt [Drug Therapy], gs 444217/po [Oral Drug Administration], gs 444217/pd [Pharmacology], albuminuria, animal cell, animal experiment, animal model, animal tissue, article, cell loss, controlled study, diabetic nephropathy/dt [Drug Therapy], disease course, early intervention, enzyme inhibition, glomerulosclerosis, glucose blood level, hypertension, IC50, in vitro study, Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/41052Test
Diabetes
LibKey Link